 |
|
Adiposity, Adult Weight Change, and Postmenopausal Breast Cancer Risk
Jiyoung Ahn, PhD;
Arthur Schatzkin, MD, DrPH;
James V. Lacey Jr, PhD;
Demetrius Albanes, MD;
Rachel Ballard-Barbash, MD;
Kenneth F. Adams, PhD;
Victor Kipnis, PhD;
Traci Mouw, MPH;
Albert R. Hollenbeck, PhD;
Michael F. Leitzmann, MD, DrPH
Arch Intern Med. 2007;167(19):2091-2102.
Background Obesity is a risk factor for postmenopausal breast cancer, but the role of the timing and amount of adult weight change in breast cancer risk is unclear.
Methods We prospectively examined the relations of adiposity and adult weight change to breast cancer risk among 99 039 postmenopausal women in the National Institutes of Health–AARP Diet and Health Study. Anthropometry was assessed by self-report in 1996. Through 2000, 2111 incident breast cancer cases were ascertained.
Results Current body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared), BMI at ages 50 and 35 years, and waist-hip ratio were associated with increased breast cancer risk, particularly in women not using menopausal hormone therapy (MHT). Weight gained between age 18 years and the current age, between ages 18 and 35 years, between ages 35 and 50 years, and between age 50 years and the current age was consistently associated with increased breast cancer risk in MHT nonusers (relative risk [RR], 2.15; 95% confidence interval [CI], 1.35-3.42 for a  50-kg weight gain between age 18 years and the current age vs stable weight) but not in current MHT users. Risk associated with adult weight change was stronger in women with later vs earlier age at menarche (RR, 4.20; 95% CI, 2.05-8.64 for 15 years vs RR, 1.51; 95% CI, 1.11-2.06 for 11-12 years; P = .007 for interaction). In MHT nonusers, the associations with current BMI and adult weight change were stronger for advanced disease than for nonadvanced disease (P = .009 [current BMI] and .21 [weight gain] for heterogeneity) and were stronger for hormone receptor–positive than hormone receptor–negative tumors (P < .001 for heterogeneity).
Conclusion Weight gain throughout adulthood is associated with increased postmenopausal breast cancer risk in MHT nonusers.
Author Affiliations: Divisions of Cancer Epidemiology and Genetics (Drs Ahn, Schatzkin, Lacey, Albanes, Adams, and Leitzmann and Ms Mouw), Cancer Control and Population Sciences (Dr Ballard-Barbash), and Cancer Prevention (Dr Kipnis), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and AARP, Washington, DC (Dr Hollenbeck).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Subcellular Localization of Cyclic AMP-Responsive Element Binding Protein-Regulated Transcription Coactivator 2 Provides a Link between Obesity and Breast Cancer in Postmenopausal Women
Brown et al.
Cancer Res. 2009;69:5392-5399.
ABSTRACT
| FULL TEXT
Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk
Cummings et al.
JNCI J Natl Cancer Inst 2009;101:384-398.
ABSTRACT
| FULL TEXT
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Gunter et al.
JNCI J Natl Cancer Inst 2009;101:48-60.
ABSTRACT
| FULL TEXT
Obesity, Mammography Use and Accuracy, and Advanced Breast Cancer Risk
Kerlikowske et al.
JNCI J Natl Cancer Inst 2008;100:1724-1733.
ABSTRACT
| FULL TEXT
Opportunities and Strategies for Breast Cancer Prevention Through Risk Reduction
Mahoney et al.
CA Cancer J Clin 2008;0:CA.2008.0016v1-CA.2008.0016.
ABSTRACT
| FULL TEXT
Child-to-Adult Body Mass Index and Height Trajectories: A Comparison of 2 British Birth Cohorts
Li et al.
Am J Epidemiol 2008;168:1008-1015.
ABSTRACT
| FULL TEXT
Prospective Evaluation of Risk Factors for Male Breast Cancer
Brinton et al.
JNCI J Natl Cancer Inst 2008;100:1477-1481.
ABSTRACT
| FULL TEXT
Secondary Effects of Antipsychotics: Women at Greater Risk Than Men
Seeman
Schizophr Bull 2008;0:sbn023v1-sbn023.
ABSTRACT
| FULL TEXT
|
